CClinicalTrials.gg
CompletedNCT06934031Updated Feb 4, 2026

Interpretation Performance in Chinese and Japanese Medical Consultation Scenarios

An observational study in Outpatients, Cardiology and Pulmonology, sponsored by Fu Jen Catholic University. Completed at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Fu Jen Catholic University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to compare the translation and interpretation performance of ChatGPT, Google Translate(GT),and UD Talk in cardiopulmonary consultations and analyze their effectiveness in addressing language barriers.The investigators hypothesize that ChatGPT and UD Talk will outperform GT in terms of accuracy and error rates.

Read the detailed description

Background: Language barriers in healthcare have a significant impact on patient safety, health outcomes, and the quality of healthcare services. With the increase in global migration, more patients are facing language challenges in foreign healthcare systems. Literature shows that providing professional interpretation services significantly improves patient satisfaction and communication quality. However, due to the high usage of ad-hoc interpreters and the shortage of professional interpreters, clinical communication quality has declined.

Study Design: This is a one-year, single-center, prospective observational study. Methods: The study will be conducted in the cardiology and pulmonology outpatient clinics at Fu Jen University Hospital. A total of 20 cardiopulmonary disease patients will be enrolled, withtheir consultation sessions recorded and transcribed into Chinese. The study will compare the three tools' performance in terms of semantic accuracy, error types, and severity, and analyze their feasibility in clinical practice. Further analysis will involve satisfaction surveys from both professional interpreters and non-native speakers living in Taiwan. The translation results will be evaluated for accuracy and error rates by 8 professional medical interpreters, with a satisfaction survey completed by a total of 14 non-experts. The evaluation tool will be based on the assessment rubrics from the National Accreditation Authority for Translators and Interpreters.

Effect: It is expected that ChatGPT and UD Talk will show better translation accuracy and interpretation quality compared to GT. UD Talk is anticipated to perform better than the other two tools in real-time interpretation. The study results will provide valuable insights for future medical interpretation training and clinical applications.

02

Conditions studied

  • Outpatients
  • Cardiology
  • Pulmonology

Keywords

  • Language barriers
  • medical communication
  • medical interpretation
  • cardiopulmonary disease
  • translation software
03

In context

Pulmonary Heart Disease

50 studies on the registry are indexed under Pulmonary Heart Disease; 8 are open to participants now.

This study's enrollment of 42 is below the median of 150 across 21 observational studies indexed under Pulmonary Heart Disease.

Browse Pulmonary Heart Disease studies →

Lead sponsor

Fu Jen Catholic University is the lead sponsor of 43 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

First part

  • Patients visiting the Cardiology or Pulmonology Department

Second part

  • Has completed Japanese-Chinese medical interpretation training and has clinical experience

Third part

  • Non-native Chinese-speaking Japanese residents

Eligibility criteria

First part

Inclusion Criteria:

  • Age over 18 years
  • Patients visiting the Cardiology or Pulmonology Department at Fu Jen Catholic University Hospital from December 2024 to November 2025

Exclusion Criteria:

  • Patients unable to communicate effectively as assessed by the physician
  • Refusal to participate in the study

Second part

Inclusion Criteria:

  • Age over 18 years
  • Completed the Japanese-Chinese medical interpretation training course and has at least two years of clinical experience

Exclusion Criteria:

  • Refusal to participate in the study

Third part

Inclusion Criteria:

  • Age over 18 years
  • Non-native Chinese-speaking Japanese residents who have lived in Taiwan for at least two years

Exclusion Criteria:

  • Refusal to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (actual)
Patient registry
No

Interventions

  • Othertranslation software

    ChatGPT, Google Translate, and UD talk

06

What researchers measure

Primary outcomes

  1. Translation Assessment Scale Score

    6-point Likert scale, with 5 representing the highest score and 0 representing the lowest.

    Time frame: 4 months

07

Study locations

1 site
  • Fu Jen Catholic University Hospital, Fu Jen Catholic University
    New Taipei City, 24352, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06934031
Lead sponsor
Fu Jen Catholic University
Responsible party
Ke-Yun, Chao (Assistant Professor, Fu Jen Catholic University) — Principal investigator
First posted
Apr 18, 2025
Start date
Apr 10, 2025
Primary completion
Nov 18, 2025
Completion
Nov 18, 2025
Last update
Feb 4, 2026

Study contacts

Ke-Yun Chao, PhD
principal investigator · Fu Jen Catholic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion